Pyrazolopyrimidines as attractive pharmacophores in efficient drug design: A recent update
1SRMPP Government First Grade College, Huvinahadagali, Karnataka, India.
Abstract:
Among the menacing diseases, cancer needs the most attention as millions of people are affected by it worldwide. Genetic and environmental factors play a pivotal role in causing cancer. Although a wide range of underlying mechanisms of cancer has been discovered, efficient treatments have not been discovered to date. Additionally, diseases caused by microbes such as viruses, bacteria, protozoa, and so forth, persistently result in several deaths. Also, inflammation is a major factor that leads to several health issues. For decades, drug design has become a major part of drug discovery and development for curing various diseases. Among the large number of pharmacological agents that have been synthesized, only very few have emerged as efficient drug molecules. Most of them are heterocyclic compounds, which are promising candidates for the design of efficient drug molecules. Furthermore, fused heterocycles showed comparatively stronger pharmacological activities than monocyclic heterocycles. The literature reveals that pyrazolopyrimidines have outstanding biological activity. Hence, here, the diverse pharmacological activities shown by pyrazolopyrimidine derivatives reported in the last 5 years are collated and reviewed systematically. This review is classified into various sections focusing on anticancer, antimicrobial, anti-inflammatory, and enzyme inhibitors. Structure-activity relationships are discussed in brief, which will help researchers design potent pharmacological agents.
Insights
Fused heterocyclic compounds, specifically pyrazolopyrimidines, show significant potential as drug candidates. This review highlights their diverse anticancer, antimicrobial, and anti-inflammatory activities, aiding future drug design.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Drug Discovery
Background:
- Cancer, microbial infections, and inflammation are major global health concerns with limited effective treatments.
- Heterocyclic compounds, particularly fused systems, are crucial scaffolds in modern drug design.
- Pyrazolopyrimidines have demonstrated significant biological activities, making them promising therapeutic agents.
Purpose of the Study:
- To systematically review the diverse pharmacological activities of pyrazolopyrimidine derivatives.
- To focus on anticancer, antimicrobial, anti-inflammatory, and enzyme inhibitory properties.
- To provide insights into structure-activity relationships for future drug design.
Main Methods:
- Comprehensive literature search of pyrazolopyrimidine derivatives reported in the last five years.
- Categorization of reviewed studies based on pharmacological activity (anticancer, antimicrobial, anti-inflammatory, enzyme inhibitors).
- Analysis and brief discussion of structure-activity relationships.
Main Results:
- Pyrazolopyrimidine derivatives exhibit a broad spectrum of potent pharmacological activities.
- Significant anticancer, antimicrobial, and anti-inflammatory effects were documented.
- Enzyme inhibitory activities were also reported for various derivatives.
Conclusions:
- Pyrazolopyrimidine derivatives represent a valuable class of compounds for developing novel therapeutic agents.
- Further research into structure-activity relationships can optimize the design of potent drugs.
- These compounds hold promise for addressing unmet medical needs in cancer, infectious diseases, and inflammatory conditions.
Related Concept Videos
Basicity of Heterocyclic Aromatic Amines
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Drug Discovery: Overview
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacogenomics: Identification of New Drug Targets


